Search for Clinical Trials
A phase 2, randomized, investigator and participant blinded, placebo-controlled, parallel-group study to investigate the safety, tolerability, and鈥�
ACCLAIM-Lp(a) is a clinical research study for people who have or are at risk for heart disease, stroke, or peripheral artery disease. Lipoprotein(a鈥�
Around 1 in 5 people inherit raised levels of a sticky particle called Lp(a) (or lipoprotein(a)) that can lead to cardiovascular disease. So if鈥�
A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH (鈥�
The purpose of this study is to evaluate the efficacy of an investigational drug on triglyceride level in patients with familial chylomicronemia鈥�
The purpose of this study is to evaluate the efficacy and safety of an investigational drug in patients with severe hypertriglyceridemia.鈥�
The purpose of this study is to evaluate the efficacy and safety of an investigational drug in patients with mixed dyslipidemia. Participants will鈥�
Lp(a)HORIZON is an outcome study to determine whether treatment with an investigational drug reduces risk for major cardiovascular events in patients鈥�
